Evaluating the risk factors for liver injury in patients with chronic lymphocytic leukemia in the dynamics of chemotherapy

Journal Title: Гастроентерологія - Year 2019, Vol 53, Issue 2

Abstract

Background. B-cell chronic lymphocytic leukemia (B-CLL) treatment is accompanied by a risk of liver injury due to factors that depend on the characteristics of the patient, tumor, and chemotherapy (CT). The purpose was to assess the risk of development and nature of liver injury in patients with B-CLL in the dynamics of CT. Materials and methods. Seventy-six patients with В-CLL were examined, including 44 (57.9 %) men and 32 (42.1 %) women. The average age was (66.81 ± 12.50) years. The B-CLL stage was determined according to the Rai (1975, 1987) and Binet (1981, 2006) classifications. CT was administered in FC (fludarabine, cyclophosphamide) regimen. The patients were examined twice: before CT and after two FC courses. Hyperplastic syndrome and hyperleukocytosis were taken into account. Biochemical blood tests were evaluated. Common Terminology Criteria for Adverse Events, version 4.02, were used. Results. Advanced B-CLL stages (stage IV (C) according to Rai, Binet) are associated with an increased risk of no response on CT (risk ratio (RR) = 0.53; 95% confidence interval (CI) = 0.31–0.90; p < 0.05). The presence of hyperplastic syndrome is accompanied by a significant risk of no response on CT (RR = 0.23; 95% CI = 0.07–0.80; p < 0.05). Liver injury is more often detected in patients with B-CLL stages III (RR = 1.96; 95% CI = 1.33–2.88; p < 0.05) and IV (RR = 2.13; 95% CI = 1.47–3.08; p < 0.05) versus stage II by Rai. In patients with B-CLL, the risk of hepatotoxic reactions development is associated with low efficacy of CT, namely the achievement of partial response (RR = 3.18; 95% CI = 1.93–5.22; p < 0.05) and no response on CT (RR = 3.71; 95% СІ = 2.37–5.81; р < 0.05). Conclusions. The risk of liver injury increases in patients with B-CLL stage IV (C) and is associated with low CT efficacy.

Authors and Affiliations

G. S. Maslova, I. M. Skrypnyk

Keywords

Related Articles

Topicality of identification of free fatty acids pattern in biologic substrates n the diagnosis of gastroenterological diseases

The article shows the role of free fatty acids in the pathogenesis of metabolic and gastroenterological disorders. An expediency of gas chromatography method for determination of free fatty acids pattern in biologic samp...

Features of clinical Picture in Patients with GERD Combined with Oddi’s Sphincter Dysfunction

This article is devoted to the study of clinical manifestations in patients with the comorbid diseases, such as gastroesophageal reflux disease and Oddi’s sphincter dysfunction. There were 78 patients included into the s...

The role of bile acids in morphological changes оf gastric mucosa in rats

The present study was conducted on 60 white male laboratory rats in order to investigate the role of bile acids in morphofunctional changes of gastric mucosa in rats with due regard to exposure of bile and its concentrat...

Clinical case in a female patient with irritable bowel syndrome

Irritable bowel syndrome (IBS) is one of the most common digestive system diseases. The article presents a clinical case in a female patient M. diagnosed with IBS with a predominance of diarrhea (in accordance with the R...

Alcohol-Induced Liver Injury: Morphological and Biochemical Features (Experimental Study)

Study concerning the influence of additional damaging factors and chronic alcoholisation on the phospholipid composition of liver homogenate has been carried out on 42 white laboratory rats using biochemical, pathomorpho...

Download PDF file
  • EP ID EP582154
  • DOI 10.22141/2308-2097.53.2.2019.168986
  • Views 63
  • Downloads 0

How To Cite

G. S. Maslova, I. M. Skrypnyk (2019). Evaluating the risk factors for liver injury in patients with chronic lymphocytic leukemia in the dynamics of chemotherapy. Гастроентерологія, 53(2), 123-127. https://europub.co.uk/articles/-A-582154